pyrroles has been researched along with Lymphoma, T Cell, Peripheral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, NG; Brown, NA; Chowdhury, P; Dewar, H; Dewar, R; Elenitoba-Johnson, KSJ; Inamdar, K; Lim, MS; Murga-Zamalloa, C; Onder, O; Polk, A; Rolland, DCM; Wilcox, RA; Wolfe, A | 1 |
1 other study(ies) available for pyrroles and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Gene Expression Profiling; Humans; Lymphoma, T-Cell, Peripheral; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Mice, Inbred NOD; Mice, SCID; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |